This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Human CD282
catalog :
MCA2151
quantity :
0.2 mg
price :
325 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
TL2.1
reactivity :
human, dogs, rhesus macaque
application :
immunoprecipitation, flow cytometry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA2151
Description :
MOUSE ANTI HUMAN CD282
Specificity :
CD282
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG2a
Applications :
C, F, FN*, IP
ApplicationTypes :
Immunohistology - Frozen, Immunoprecipitation, Flow Cytometry, Functional Assays
CrossReactivities :
Cynomolgus monkey, Dog, Marmoset, Rhesus Monkey
Clone :
TL2.1
Quantity :
0.2 mg
QuantityValue :
0.2
QuantityType :
mg
GOAccessions :
GO:0001875, GO:0002755, GO:0004888, GO:0005887, GO:0005737, GO:0006917, GO:0006954, GO:0007252, GO:0008063, GO:0010552, GO:0030177, GO:0032722, GO:0032728, GO:0032735, GO:0032741, GO:0032755, GO:0032757, GO:0032760, GO:0034123, GO:0034130, GO:0034134, GO:0034142, GO:0035354, GO:0042346, GO:0042495, GO:0042496, GO:0042497, GO:0042834, GO:0045087, GO:0046982, GO:0050729, GO:0051092, GO:0051637, GO:0051770, GO:0071223, GO:0071726, GO:0071727
GOTerms :
activation of apoptosis, activation of chemokine production, activation of frizzled signaling pathway, activation of inflammatory response, activation of interferon-beta production, activation of interleukin-12 production, activation of interleukin-18 production, activation of interleukin-6 production, activation of interleukin-8 production, activation of NF-kappaB, activation of NF-kappaB import into nucleus, activation of NF-kappaB transcription factor, activation of nitric-oxide synthase biosynthetic process, activation of tumor necrosis factor production, activation of Wnt receptor signaling pathway, apoptosis activator activity, apoptosis signaling, bacterial triacyl lipopeptide binding, bacterial triacyl lipoprotein binding, binding to Gram-positive bacterium, cellular response to diacylated bacterial lipoprotein, cellular response to LTA, cellular response to triacylated bacterial lipoprotein, commitment to apoptosis, detection of diacylated bacterial lipoprotein, detection of triacylated bacterial lipoprotein, endotoxin receptor activity, GO:0002226, GO:0004926, GO:0045811, GO:0051076, Gram-positive bacterial binding, Gram-positive bacterium binding, Gram-positive bacterium cell surface binding, induction of apoptosis by p53, LPS receptor activity, MyD88-dependent TLR signaling pathway, MyD88-dependent toll-like receptor signalling pathway, NF-kappaB activation, non G protein coupled 7TM receptor activity, non-G-protein coupled 7TM receptor activity, non-G-protein-coupled 7TM receptor activity, nonspecific immune response, perception of diacylated bacterial lipopeptide, perception of diacylated bacterial lipoprotein, perception of triacylated bacterial lipopeptide, perception of triacylated bacterial lipoprotein, positive regulation of frizzled signaling pathway, positive regulation of frizzled signalling pathway, positive regulation of IFN-beta production, positive regulation of IL-12 production, positive regulation of IL-18 production, positive regulation of IL-6 production, positive regulation of IL-8 production, positive regulation of NF-kappaB import into cell nucleus, positive regulation of NF-kappaB transport from cytoplasm to nucleus, positive regulation of NF-kappaB-nucleus import, positive regulation of NO synthase biosynthesis, positive regulation of NO synthase biosynthetic process, positive regulation of NOS biosynthesis, positive regulation of NOS biosynthetic process, positive regulation of TLR signaling pathway, positive regulation of TNF production, positive regulation of TNF-alpha production, positive regulation of toll-like receptor signalling pathway, positive regulation of tumor necrosis factor-alpha production, positive regulation of Wnt receptor signalling pathway, stimulation of chemokine production, stimulation of frizzled signaling pathway, stimulation of inflammatory response, stimulation of interferon-beta production, stimulation of interleukin-12 production, stimulation of interleukin-18 production, stimulation of interleukin-6 production, stimulation of interleukin-8 production, stimulation of NF-kappaB import into nucleus, stimulation of nitric-oxide synthase biosynthetic process, stimulation of tumor necrosis factor production, stimulation of Wnt receptor signaling pathway, Tl signaling pathway, Tl signalling pathway, TLR1 signaling pathway, TLR1-TLR2 protein complex, TLR2 signaling pathway, TLR4 signaling pathway, Toll signalling pathway, toll-like receptor 1 signalling pathway, toll-like receptor 2 signalling pathway, toll-like receptor 4 signalling pathway, triacylated lipopeptide binding, up regulation of chemokine production, up regulation of frizzled signaling pathway, up regulation of inflammatory response, up regulation of interferon-beta production, up regulation of interleukin-12 production, up regulation of interleukin-18 production, up regulation of interleukin-6 production, up regulation of interleukin-8 production, up regulation of NF-kappaB import into nucleus, up regulation of nitric-oxide synthase biosynthetic process, up regulation of tumor necrosis factor production, up regulation of Wnt receptor signaling pathway, upregulation of chemokine production, up-regulation of chemokine production, upregulation of frizzled signaling pathway, up-regulation of frizzled signaling pathway, upregulation of inflammatory response, up-regulation of inflammatory response, up-regulation of interferon-beta production, upregulation of interferon-beta production, up-regulation of interleukin-12 production, upregulation of interleukin-12 production, up-regulation of interleukin-18 production, upregulation of interleukin-18 production, up-regulation of interleukin-6 production, upregulation of interleukin-6 production, up-regulation of interleukin-8 production, upregulation of interleukin-8 production, up-regulation of NF-kappaB import into nucleus, upregulation of NF-kappaB import into nucleus, up-regulation of nitric-oxide synthase biosynthetic process, upregulation of nitric-oxide synthase biosynthetic process, upregulation of tumor necrosis factor production, up-regulation of tumor necrosis factor production, upregulation of Wnt receptor signaling pathway, up-regulation of Wnt receptor signaling pathway
UniprotAccessions :
O60603
Gene :
TLR2
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7097
PublishedSynonyms :
TLR2
EntityFormats :
Purified
UNSPSC :
12352203
Concentration :
IgG concentration 0.5 mg/ml
ProductForm :
Purified IgG - liquid
PriceDKK :
2419
PrimarySecondary :
Primary
PriceGBP :
232
PriceEUR :
325
PriceUSD :
325 USD
PriceCHF :
381
PriceSEK :
3240
PriceNOK :
3219
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments